Growth Metrics

Vertex Pharmaceuticals (VRTX) Assets Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.75%
Dec 31, 2025 13.80%
Sep 30, 2025 11.79%
Jun 30, 2025 19.39%
Mar 31, 2025 -4.34%
Dec 31, 2024 -0.87%
Sep 30, 2024 2.37%
Jun 30, 2024 -1.07%
Mar 31, 2024 26.05%
Dec 31, 2023 25.23%
Sep 30, 2023 30.05%
Jun 30, 2023 30.59%
Mar 31, 2023 33.10%
Dec 31, 2022 35.13%
Sep 30, 2022 32.39%
Jun 30, 2022 27.50%
Mar 31, 2022 17.67%
Dec 31, 2021 14.30%
Sep 30, 2021 11.65%
Jun 30, 2021 19.63%
Mar 31, 2021 36.23%
Dec 31, 2020 41.27%
Sep 30, 2020 50.40%
Jun 30, 2020 45.25%
Mar 31, 2020 35.92%
Dec 31, 2019 33.18%
Sep 30, 2019 62.62%
Jun 30, 2019 62.23%
Mar 31, 2019 65.52%
Dec 31, 2018 76.14%
Sep 30, 2018 44.48%
Jun 30, 2018 31.95%
Mar 31, 2018 34.15%
Dec 31, 2017 22.41%
Sep 30, 2017 22.56%
Jun 30, 2017 28.90%
Mar 31, 2017 18.44%
Dec 31, 2016 15.94%
Sep 30, 2016 7.22%
Jun 30, 2016 7.37%
Mar 31, 2016 14.87%
Dec 31, 2015 7.02%
Sep 30, 2015 1.16%
Jun 30, 2015 12.10%
Mar 31, 2015 -1.42%
Dec 31, 2014 0.67%
Sep 30, 2014 -6.84%
Jun 30, 2014 -18.05%
Mar 31, 2014 -8.16%
Dec 31, 2013 -15.96%
Sep 30, 2013 -5.00%
Jun 30, 2013 -0.79%
Mar 31, 2013 1.98%
Dec 31, 2012 25.18%
Sep 30, 2012 29.96%
Mar 31, 2012 52.48%
Dec 31, 2011 27.75%
Sep 30, 2011 10.76%
Mar 31, 2011 -13.09%
Dec 31, 2010 -11.76%